Company Profile

Aditxt, Inc. Stock Price, News & Analysis

Ticker:
ADTX
Exchange:
NASDAQ
Sector:
Biopharma
Location:
United States

Stock performance

0.00 USD (0.00%)

Close

Last updated: August 6, 2026

89.6K USD

Market cap

Why the stock is moving

As of Aug 6, 2026, ADTX was little changed and closed at $0.0028. No new same-company headline was identified in the current news window.

Company overview

Business overview

Aditxt is a biotechnology and platform company focused on immune monitoring, diagnostics, and related precision-health applications. Its story blends biomarker science with a broader health-platform ambition.

Geographic Base and Sector Classification

Aditxt is headquartered in the United States and listed on NASDAQ. It sits in biotech and diagnostics-adjacent platforms.

Business Model Characteristics

The business depends on platform adoption, partnerships, and the ability to convert immune-monitoring concepts into revenue. Investors usually watch strategic changes and commercial traction.

Position Within the Biotechnology Landscape

Aditxt occupies a platform-health niche within the biotech ecosystem. It is more of a precision-health and diagnostics story than a classic therapeutics name.

Future catalysts

Aditxt’s catalysts are immune-monitoring and biotech-platform updates, plus any strategic step that clarifies the company’s future. The company still needs a more concrete operating path.

Recent news

  1. 01

Similar stocks

Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

Frequently Asked Questions

What is the current stock price of Aditxt, Inc. (ADTX)?

Aditxt, Inc. (ADTX) most recently closed at 0.00 USD, a 0.00% move versus the previous session.

What is the market cap of Aditxt, Inc. (ADTX)?

Aditxt, Inc. currently has a market capitalization of 89.6K USD on BioPharmSignal.

What does Aditxt, Inc. do?

Aditxt is a biotechnology and platform company focused on immune monitoring, diagnostics, and related precision-health applications. Its story blends biomarker science with a broader health-platform ambition.

On which exchange is ADTX stock listed?

Aditxt, Inc. (ADTX) is associated with NASDAQ, United States, Biopharma.

What is Aditxt?

Aditxt’s catalysts are immune-monitoring and biotech-platform updates, plus any strategic step that clarifies the company’s future.

Which conditions is Aditxt, Inc. targeting with Aditxt?

Aditxt’s catalysts are immune-monitoring and biotech-platform updates, plus any strategic step that clarifies the company’s future.

How does Aditxt, Inc. describe recent progress with Aditxt?

Aditxt’s catalysts are immune-monitoring and biotech-platform updates, plus any strategic step that clarifies the company’s future.

What future catalysts are investors watching for Aditxt, Inc.?

Aditxt’s catalysts are immune-monitoring and biotech-platform updates, plus any strategic step that clarifies the company’s future. The company still needs a more concrete operating path.